Cargando…

Immunotherapy – The New Era of Oncology

In the field of immunotherapy, essential progress was achieved over the past years partially demonstrating long lasting therapeutic responses in different tumor entities. A better understanding of the interactions between the tumor and the immune system as well as the integration of immunotherapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kansy, Benjamin, Lang, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541097/
https://www.ncbi.nlm.nih.gov/pubmed/29905353
http://dx.doi.org/10.1055/s-0043-121594
_version_ 1783422716941959168
author Kansy, Benjamin
Lang, Stephan
author_facet Kansy, Benjamin
Lang, Stephan
author_sort Kansy, Benjamin
collection PubMed
description In the field of immunotherapy, essential progress was achieved over the past years partially demonstrating long lasting therapeutic responses in different tumor entities. A better understanding of the interactions between the tumor and the immune system as well as the integration of immunotherapeutic approaches into clinical routine were the foundations for this development. The different approaches intervene on multiple levels of the immune response and directly or indirectly mount the patient‘s own immune defense against tumor cells. Immunotherapeutic approaches are represented by cytokine therapies, vaccinations, the use of oncolytic viruses and monoclonal antibody therapies as well as adoptive cell transfer strategies.
format Online
Article
Text
id pubmed-6541097
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher © Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-65410972019-05-30 Immunotherapy – The New Era of Oncology Kansy, Benjamin Lang, Stephan Laryngorhinootologie In the field of immunotherapy, essential progress was achieved over the past years partially demonstrating long lasting therapeutic responses in different tumor entities. A better understanding of the interactions between the tumor and the immune system as well as the integration of immunotherapeutic approaches into clinical routine were the foundations for this development. The different approaches intervene on multiple levels of the immune response and directly or indirectly mount the patient‘s own immune defense against tumor cells. Immunotherapeutic approaches are represented by cytokine therapies, vaccinations, the use of oncolytic viruses and monoclonal antibody therapies as well as adoptive cell transfer strategies. © Georg Thieme Verlag KG 2018-03 2018-03-22 /pmc/articles/PMC6541097/ /pubmed/29905353 http://dx.doi.org/10.1055/s-0043-121594 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Kansy, Benjamin
Lang, Stephan
Immunotherapy – The New Era of Oncology
title Immunotherapy – The New Era of Oncology
title_full Immunotherapy – The New Era of Oncology
title_fullStr Immunotherapy – The New Era of Oncology
title_full_unstemmed Immunotherapy – The New Era of Oncology
title_short Immunotherapy – The New Era of Oncology
title_sort immunotherapy – the new era of oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541097/
https://www.ncbi.nlm.nih.gov/pubmed/29905353
http://dx.doi.org/10.1055/s-0043-121594
work_keys_str_mv AT kansybenjamin immunotherapytheneweraofoncology
AT langstephan immunotherapytheneweraofoncology